Jim Mullen And Sandra Poole Talk About Modern Approaches To Data Management At Upcoming Boston Forum

Skyland Analytics is hosting a complimentary Lunch Forum on Modern Approaches to Data Management Challenges in Drug Development and Manufacturing on April 11^th at 11:45am. It will be presented at the Boston office of the Cooley law firm. Prominent industry speakers will include James Mullen (former CEO Patheon and Biogen), Sandra Poole (former EVP, Immunogen and SVP, Genzyme) and Caroline Dugopolski (VP of Tech Ops at Histogenics).

The forum will cover topics such as data management challenges in an increasingly complex supply chain, the evolving regulatory landscape and recent focus on data integrity (FDA and SEC), and new approaches to compliant data management in virtual and global manufacturing networks.

Caroline Dugopolski of Histogenics will share a case study on how her team has used Skyland’s Process Information Management Suite (PIMS) for process characterization, the development and management of process specifications and target control limits, and knowledge and document management.

About Skyland Analytics
Skyland Analytics develops data analytics and data management software for pharmaceutical and biotechnology companies managing manufacturing processes and product quality across internal and external networks. Skyland’s recent product release, Skyland PIMS, equips manufacturers with a simple, validatable, cloud-based workspace for product, process and batch data. This market-leading software enables access across the manufacturing network to essential data that supports monitoring, ad hoc investigations, process analysis, Continued Process Verification (CPV) management and other critical initiatives. For more about Skyland PIMS and other products and services, visit skylandanalytics.net.